raloxifene hydrochloride has been researched along with Glucose Intolerance in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, JH; Kim, YJ | 1 |
| Ando, H; Kaneko, S; Komura, T; Matsushita, E; Minato, H; Shimizu, A; Takamura, T; Zen, Y | 1 |
2 other study(ies) available for raloxifene hydrochloride and Glucose Intolerance
| Article | Year |
|---|---|
Effects of genistein in combination with conjugated estrogens on endometrial hyperplasia and metabolic dysfunction in ovariectomized mice.
Topics: Adiposity; Animals; Diet, High-Fat; Dietary Supplements; Endometrial Hyperplasia; Endometrium; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Genistein; Glucose Intolerance; Liver; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Ovariectomy; Overweight; Phytoestrogens; Raloxifene Hydrochloride; Random Allocation; Selective Estrogen Receptor Modulators | 2015 |
Selective estrogen receptor modulator raloxifene-associated aggravation of nonalcoholic steatohepatitis.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Fatty Liver; Female; Glucose Intolerance; Humans; Insulin Resistance; Liver; Liver Cirrhosis; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Severity of Illness Index | 2007 |